MacroGenics Issuance Of Capital Stock from 2010 to 2025

MGNX Stock  USD 2.77  0.21  7.05%   
MacroGenics Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock will likely drop to about 526.7 K in 2025. During the period from 2010 to 2025, MacroGenics Issuance Of Capital Stock regression line of annual values had r-squared of  0.35 and arithmetic mean of  83,690,255. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
554.4 K
Current Value
526.7 K
Quarterly Volatility
52.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.7 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 3.69. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of MacroGenics over the last few years. It is MacroGenics' Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Slightly volatile
   Issuance Of Capital Stock   
       Timeline  

MacroGenics Issuance Of Capital Stock Regression Statistics

Arithmetic Mean83,690,255
Geometric Mean30,693,970
Coefficient Of Variation62.41
Mean Deviation41,497,368
Median103,259,000
Standard Deviation52,226,943
Sample Variance2727.7T
Range169.9M
R-Value(0.60)
Mean Square Error1886.8T
R-Squared0.35
Significance0.01
Slope(6,530,429)
Total Sum of Squares40914.8T

MacroGenics Issuance Of Capital Stock History

2025526.7 K
2024554.4 K
2023616 K
20221.1 M
2021117.8 M
2020170.5 M
2019118.7 M

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock554.4 K526.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.